Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-05-19

FDA Approved: ADVIL ALLERGY SINUS — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application for Advil Allergy Sinus, a multi-ingredient combination product from Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVIL ALLERGY SINUS (chlorpheniramine maleate, ibuprofen, pseudoephedrine HCl)

Snippet

SUPPL AP for ADVIL ALLERGY SINUS (CHLORPHENIRAMINE MALEATE, IBUPROFEN, PSEUDOEPHEDRINE HCL)